Clinical Trial Update: A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

The document notes that InventisBio's D-0502 is being evaluated in a Phase 3 trial for ER-positive, HER2-negative locally advanced or metastatic breast cancer a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• D-0502

Snippet

Sponsor: InventisBio Co., Ltd | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING